FSC group 65, part i, section b - drugs, pharmaceuticals & hematology related products
Ended Awarded Last action
- Contract number
- V797P5226B
- Awardee
-
Takeda Pharmaceuticals America, Inc. UEI ENNFDLWFC6L1 Part of Takeda Pharmaceutical Company LIMITED
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 0
Award facts
- Opportunity
-
- Millennium Pharmaceuticals, Inc. 65IB - Drugs, Pharmaceuticals and Hematology Related Products Award Notice · Posted Oct 26, 2010
- Last date to order 100% complete
- IDV ceiling
- $54,500,000.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
- Legislative mandates
-
- Other statutory authority
Award details come from SAM.gov/FPDS.
About this IDV
GSA issued a Federal Supply Schedule contract to Takeda Pharmaceuticals America, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) schedule on March 1, 2011, with a ceiling value of $54.5 million and an ultimate completion date of September 30, 2018; this contract was canceled effective July 9, 2026 and replaced by a new contract.
The contract covered FSC Group 65, Part I, Section B — drugs, pharmaceuticals, and hematology-related products — as a multiple-award vehicle. Performance occurred at locations including Earth City, Missouri and Cambridge, Massachusetts. The contract was funded through Veterans Integrated Service Network 12 and carried no small business set-aside designation.
Takeda supplied specialized pharmaceutical products to the VA healthcare system, including oncology medications such as ICLUSIG (ponatinib) in multiple dosage strengths (10 milligram, 15 milligram, 30 milligram, and 45 milligram tablets) for treatment of chronic myeloid leukemia and acute lymphoblastic leukemia. Delivery orders under this schedule were issued by multiple VISNs including VISN 5, VISN 6, VISN 9, VISN 10, VISN 12, VISN 20, VISN 21, VISN 22, and VISN 23, with individual orders ranging from approximately $11,000 to $173,000. Takeda also received delivery orders from the Federal Correctional Complex Florence for chemotherapy medications, demonstrating use of the schedule beyond VA facilities. All delivery orders were issued as firm fixed-price contracts.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Legal Contract Cancellation | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Exercise an Option | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 42
Quick answers
Who was awarded contract V797P5226B?
V797P5226B was awarded to Takeda Pharmaceuticals America, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on March 1, 2011.
How much is contract V797P5226B worth?
V797P5226B's own ceiling is $54,500,000.
Who can order from contract V797P5226B?
V797P5226B is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract V797P5226B part of a contract vehicle?
Yes. V797P5226B is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract V797P5226B competed?
The extent of competition for V797P5226B was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV